Stability of 3′-Deoxy-3′-[18F]fluorothymidine standardized uptake values in head and neck cancer over time

Cancer Biotherapy and Radiopharmaceuticals

Volumn 25, Issue 3, 2010, Pages 361-363

  Boles Ponto, Laura L ^a   Menda, Yusuf ^a   Dornfeld, Kenneth ^b   Tewson, Timothy J ^a   Watkins, G Leonard ^a   Sunderland, John ^a   Graham, Michael M ^a   Buatti, John ^c  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF MINNESOTA DULUTH   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

18F fluorothymidine; FLT; head and neck cancer; standardized uptake values

Indexed keywords

3' FLUOROTHYMIDINE F 18; CARBOPLATIN; CISPLATIN; PACLITAXEL; 2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; 3' FLUOROTHYMIDINE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; WHOLE BODY IMAGING; AGED; CLINICAL TRIAL; HEAD AND NECK TUMOR; METABOLISM; MIDDLE AGED; TIME;

AGED; CARBOPLATIN; CISPLATIN; DIDEOXYNUCLEOSIDES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TIME FACTORS;

EID: 77954930781     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2009.0709     Document Type: Article

References (7)

1. Buck AK, Bommer M, Stilgenbauer S, et al. Molecular imaging of proliferation in malignant lymphoma. Cancer Res 2006;66:11055.
2. Pio BS, Park CK, Pietras R, et al. Usefulness of 3'[F-18]Fluoro- 3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy. Mol Imaging Biol 2006;8:36.
3. Spence AM, Muzi M, Link JM, et al. NCI-Sponsored trial for the evaluation of safety and preliminary efficacy of 3'-Deoxy- 3'[18F]fluorothymidine (FLT) as a marker of proliferation in patients with recurrent gliomas: Preliminary efficacy studies. Mol Imaging Biol 2009;11:343.
4. Everitt S, Hicks RJ, Ball D, et al. Imaging cellular proliferation during chemo-radiotherapy: A pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2009;75:1098.
5. Buck A, Kratochwil C, Glatting G, et al. Early assessment of therapy response in malignant lymphoma with the thymidine analogue [18F]FLT. Eur J Nucl Med Mol Imaging 2007; 34:1775.
6. Kenny L, Coombes R, Vigushin D, et al. Imaging early changes in proliferation at 1 week post chemotherapy: A pilot study in breast cancer patients with 3'-deoxy-3'-[18F]fluor- othymidine positron emission tomography. Eur J Nucl Med Mol Imaging 2007;34:1339.
7. Menda Y, Boles Ponto LL, Dornfeld KJ, et al. Kinetic analysis of 3'-Deoxy-3'-18F-fluorothymidine (18F-FLT) in head and neck cancer patients before and early after initiation of che- moradiation therapy. J Nucl Med 2009;50:1028.